Adjuvant therapy in renal cell cancer. Analysis of clinical trials and evidence-based immunotherapy
Автор: Pavlov A.Y., Dzidzaria A.G., Gafanov R.A., Khalil I.I.
Журнал: Вестник Российского научного центра рентгенорадиологии Минздрава России @vestnik-rncrr
Рубрика: Обзоры, лекции
Статья в выпуске: 4 т.21, 2021 года.
Бесплатный доступ
The treatment of patients with advanced renal cell carcinoma is an important task of oncology. High hopes were pinned on targeted therapy, but clinical studies have shown mixed results. The most attention is drawn to the promising results of the study of immune response checkpoint inhibitors KEYNOTE-564, but the question of their application in clinical practice remains open.
Renal cell carcinoma, immunotherapy, keynote-564
Короткий адрес: https://sciup.org/149139204
IDR: 149139204
Статья научная
